Tower Research Capital LLC (Trc) Abeona Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,567 shares of ABEO stock, worth $38,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,567
Previous 5,058
69.38%
Holding current value
$38,123
Previous $28,000
60.71%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ABEO
# of Institutions
109Shares Held
32.9MCall Options Held
1.34MPut Options Held
271K-
Nantahala Capital Management, LLC New Canaan, CT4.56MShares$20.3 Million0.98% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.05MShares$13.6 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$11.9 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.6MShares$11.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.84MShares$8.2 Million1.55% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $26.5M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...